Staar Surgical
STAA • NASDAQ
Staar Surgical is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Warren Foust, with a market cap of $885.8M.
CEOWarren Foust
Next Earnings
Upcoming earnings announcement for Staar Surgical
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.04
Revenue Estimate
$68.7M
Earnings History
Past 12 earnings reports for Staar Surgical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.13Est: $0.11 | -218.2% | $57.8MEst: $75.3M | -23.2% |  10-K |
| Nov 5, 2025 | Q3 2025 | $0.18Est: $0.17 | +5.9% | $94.7MEst: $89.4M | +6.0% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.34Est: -$0.60 | +43.3% | $44.3MEst: $41.2M | +7.6% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.64Est: $0.11 | -681.8% | $42.6MEst: $83.9M | -49.3% | 10-Q |
| Feb 11, 2025 | Q4 2024 | -$0.69Est: -$0.00 | — | $49.0MEst: $77.7M | -37.0% | 10-K |
| Oct 30, 2024 | Q3 2024 | $0.20Est: $0.17 | +17.6% | $88.6MEst: $86.9M | +1.9% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.15Est: $0.24 | -37.5% | $99.0MEst: $95.2M | +4.0% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.07Est: $0.04 | -275.0% | $77.4MEst: $74.9M | +3.3% | 10-Q |
| Feb 26, 2024 | Q4 2023 | $0.16Est: $0.17 | -5.9% | $76.3MEst: $75.9M | +0.5% | 10-K |
| Nov 1, 2023 | Q3 2023 | $0.30Est: $0.18 | +66.7% | $80.3MEst: $80.3M | -0.0% | — |
| Aug 2, 2023 | Q2 2023 | $0.40Est: $0.32 | +25.0% | $92.3MEst: $93.0M | -0.8% | 10-Q |
| May 3, 2023 | Q1 2023 | $0.18Est: $0.02 | +800.0% | $73.5MEst: $67.0M | +9.8% | — |